Meet the Management of Sensorion, a biotechnology company that develops first-in-class drugs for the treatment of inner ear diseases such as severe vertigo, tinnitus or hearing loss. There is still no cure for these highly disabling conditions that affect more than 140 million people worldwide and result in very high societal costs.
Wednesday, February 21, 2018
BEDFORD Hotel 17, rue de l’Arcade – 75008 Paris
6.45 pm OPENING
7 pm CONFERENCE SENSORION – Pasquier Lounge
Nawal OUZREN, Managing Director, MSc
Paul BIKARD, Administrative and Financial Director, MSc
Pierre ATTALI, Medical Director, MD, MSc
– History
– Team
– Market for diseases of the inner ear, etiology, epidemiology
– Intellectual property and modalities of action
– Programs and clinical phases
– Collaborations and partnerships
– Financing and next steps
– Future catalysts
– Key points that the investor must remember
– Discussions
8.30 – 22.30 pm COCKTAIL – Villa Lobos Lounge
Discussions with management and networking
